Please assess the completion status of the following clinical trial:

Trial Title: Comedone Extraction and Oral Doxycycline In The First Line Treatment of Moderate Acne Vulgaris

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with moderate acne vulgaris based on clinical manifestation of face (20-100 comedones, 15-50 inflammatory lesions, and/or 30-125 total lesions)~* Age range of 15 to 50 years old~Exclusion Criteria:~* History of oral antibiotics consumption within 2 weeks preceding this study~* Usage of topical retinoid in less than previous 2 weeks~* History of systemic retinoid consumption within 3 months preceding this study~* Pregnant of breastfeeding women~* Consuming oral contraception during examination~* Drug allergy or skin manifestation due to side effect of moderate acne vulgaris first line therapy

- Gender: ALL
- Minimum Age: 15 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- Doxycycline Group (Type: PLACEBO_COMPARATOR): Subjects were randomized to receive Doxycycline capsules. The capsules were taken once daily for 6 weeks and evaluated every 2 weeks.
- Comedone Extraction Group (Type: ACTIVE_COMPARATOR): Subjects were randomized to receive comedone extraction. Comedone extraction were done three times, and evaluated every 2 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).